CEOs of Big 4 ambient AI companies shrug off competition

The CEOs of Nabla, Suki, Ambience Healthcare and Abridge separately spoke with MedCity News about why their products have staying power despite imminent competition from Epic.

Editor's Pick

Top Story Despite Competition, All Big 4 Ambient Company CEOs Believe They Will Succeed The CEOs of Nabla, Suki, Ambience Healthcare and Abridge separately spoke with MedCity News about why their products have staying power despite imminent competition from Epic. Sponsored How AI is Reshaping Care Navigation and Patient Outcomes Presented by Quantum Health In this episode, Quantum Health's Chief AI Officer, Shannon Skaggs joins the podcast.  We'll cover the importance of completeness and quality of data and how AI can be used for a patient's personal health journey. Listen now!

Featured News

Pluto Health, Help.AI Team Up to Advance Surgical Care Pluto Health and Help.AI have partnered to integrate their platforms and use AI to streamline preoperative evaluations and improve surgical safety and efficiency. FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma Kura Oncology's Komzifti is approved for treating advanced cases of acute myeloid leukemia with an NPM1 mutation. A Syndax Pharmaceuticals drug is already approved in this indication, but Kura says its drug has advantages in safety and patient convenience. Turning CMS' Guidelines into a SNF Playbook These updated guidelines are a good opportunity for SNFs to change how they operate moving forward. Those who start implementing new policies and objectives soon and begin to operate as one system, rather than prioritizing each outcome separately, will be the ones to see the greatest results. AI Clinical Decision Support: Revolutionizing the Doctor's Black Bag When designed responsibly, AI can be a powerful instrument that provides instant access to expert-curated information. As a result, clinicians can make more informed decisions without sacrificing that vital human-to-human connection. The Path to Fair PBM Competition When control over prescription drug access rests with only a few players, the result is not just market imbalance — it is higher plan costs, increased financial pressures, and ultimately reduced affordability for patients.

Video   Video: Looking for smarter health guidance? Carolyn Jasik from Verily talks about their telemedicine app linking users to licensed doctors and Violet, an AI that answers your health questions using your own medical records. Watch the interview to see how Verily is changing health access.

Resources

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? View Now

MedCity News • PO Box 901 • New York, NY unsubscribe